These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 17393746

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S, Lau S, Valovirta E.
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE, Monasterolo G, Coco G, Silvestro L, Operti D.
    Vaccine; 2007 Jan 15; 25(5):957-64. PubMed ID: 17045368
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler NN, Barlan IB.
    Clin Exp Allergy; 2010 Jun 15; 40(6):922-32. PubMed ID: 20100188
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA, Röder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Mölken MP.
    J Allergy Clin Immunol; 2013 Aug 15; 132(2):353-60.e2. PubMed ID: 23651609
    [Abstract] [Full Text] [Related]

  • 10. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA, Casale TB, Nelson HS, Demoly P.
    J Allergy Clin Immunol; 2013 Dec 15; 132(6):1322-36. PubMed ID: 24139829
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.
    Allergy; 2006 Oct 15; 61(10):1177-83. PubMed ID: 16942565
    [Abstract] [Full Text] [Related]

  • 12. Quality of life outcomes with sublingual immunotherapy.
    Wise SK, Woody J, Koepp S, Schlosser RJ.
    Am J Otolaryngol; 2009 Oct 15; 30(5):305-11. PubMed ID: 19720247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sublingual immunotherapy: the optimism and the issues.
    Pajno GB.
    J Allergy Clin Immunol; 2007 Apr 15; 119(4):796-801. PubMed ID: 17306355
    [Abstract] [Full Text] [Related]

  • 18. Advances in upper airway diseases and allergen immunotherapy.
    Nelson HS.
    J Allergy Clin Immunol; 2007 Apr 15; 119(4):872-80. PubMed ID: 17292953
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.